艾伯塔省将RSV射击限制在高风险新生儿身上,尽管国家提出了建议,但引发了人们的关切。 Alberta limits RSV shots to high-risk newborns, sparking concern despite national recommendations.

从11月开始,艾伯塔省将向有心脏病或NICU入院等条件的高危新生儿提供RSV预防性注射疫苗,但不像其他省份那样普遍。 Starting in November, Alberta will offer the RSV preventive shot nirsevimab to high-risk newborns with conditions like heart defects or NICU admissions, but not universally like other provinces. 虽然加拿大卫生部于2023年批准该药物,而NACI建议广泛使用该药物,但艾伯塔省有限的推广引起了医生的担忧,医生指出住院率和缺诊病例很高。 While Health Canada approved the drug in 2023 and NACI recommends broad use, Alberta’s limited rollout has drawn concern from doctors who cite high hospitalization rates and missed cases. 同时,安大略省扩大了对75岁以上成年人、8个月以下婴儿、高风险儿童和接受Abrysvo的孕妇的RSV保护范围。 Meanwhile, Ontario has expanded RSV protection to adults 75+, infants under eight months, high-risk children, and pregnant individuals receiving Abrysvo®. 加拿大各地的卫生官员敦促接种流感、COVID-19和RSV疫苗,指出所有这三种疫苗都可以同时接种,并建议采取诸如洗手和蒙面等预防措施。 Health officials across Canada urge vaccination against flu, COVID-19, and RSV, noting all three can be given at once and recommending preventive measures like handwashing and masking.